Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam-Reference-Cited by-同舟云学术

Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam

Published:2019-03-13 Issue:3 Volume:14 Page:e0212734
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Le Ngoc Chau,Tran Thi Thanh Thanh,Tran Thi Lan Phuong,Nguyen Mai Trinh,Nguyen Hoa Trang,Nghiem My Ngoc,Le Van Tan,Le Manh Hung,Le Thanh Phuong,Nguyen Van Vinh Chau,Thwaites Guy,Cooke Graham,Heilek Gabrielle M.,Shikuma Cecilia,Le Thuy,Baker Stephen,Rahman Motiur^ORCID,

Funder

Roche Molecular System

Wellcome Trust

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference57 articles.

1. Organization WH: Global report on access to hepatitis C treatment. Focus on overcoming barriers. 2016, October(WHO/HIV/2016.20).

2. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes;A Petruzziello,2016

3. HCV routes of transmission: what goes around comes around;MJ Alter,2011

4. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews;PK Nelson,2011

5. Acute hepatitis C;JR Orland,2001

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The best anti-HCV S/Co values for reflecting HCV infection in a university hospital in the eastern part of Turkey;The Journal of Infection in Developing Countries;2024-01-31

2. Distribution pattern, molecular transmission networks, and phylodynamic of hepatitis C virus in China;PLOS ONE;2023-12-21

3. HCV RNA Quantification by a Domestic Commercial Assay: A Case Study among People Who Inject Drugs in Vietnam;Diagnostics;2023-11-16

4. Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study;eLife;2023-01-09

5. Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for Hepatitis C: a single arm mechanistic pilot study;2022-08-17